Journal
GERIATRICS & GERONTOLOGY INTERNATIONAL
Volume 13, Issue 1, Pages 28-34Publisher
WILEY
DOI: 10.1111/j.1447-0594.2012.00922.x
Keywords
Alzheimer's disease type dementia; hypoglycemia; insulin resistance; neurocognitive assessment; vascular dementia
Categories
Funding
- Japanese Ministry of Health, Welfare and Labor
Ask authors/readers for more resources
The incidence of type 2 diabetes mellitus (T2DM) has risen, and this trend is likely to continue. Recent advances suggest that T2DM is a risk factor for cognitive decline. We are now encountering novel complications of T2DM, namely cognitive dysfunction and dementia. Although the treatment strategy for diabetic patients with neurocognitive dysfunction has received a great deal of attention, the appropriate level of glycemic control for the prevention of the development and/or progression of cognitive decline in elderly diabetic patients remains to be elucidated. Another issue in diabetic treatment in patients with cognitive dysfunction is the selection of medicines. The best choice and combination of antidiabetic medications for the preservation of cognition should also be studied. Ample studies suggest that exercise helps to preserve cognitive function, although existing evidence does not necessarily indicate its effectiveness exclusively in diabetic patients. Exercise is a helpful non-pharmacological therapy. Considering the progressive aging of the worldwide population, more research to investigate the best way to manage this population is important. Geriatr Gerontol Int 2013; 13: 28-34.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available